PTH1R and osteoporosis: However, the molecular basis for the signaling durations induced by such distinct peptide ligands of PTH1R remains obscure, which hampering further drug optimization and the development of effective, orally available non-peptide agonists for the treatment of osteoporosis and the dysregulations of mineral ion homeostasis.